SGH
MNTA

Sivik Global Healthcare’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Sivik Global Healthcare’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-90,000
Closed -$1.48M – 67
2015
Q3 		$1.48M Sell
90,000
-20,000
-18% -$409K 0.72% 51
2015
Q2 		$2.51M Buy
110,000
+10,000
+10% +$199K 0.87% 46
2015
Q1 		$1.52M Buy
+100,000
New +$1.3M 0.52% 66

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Sivik Global Healthcare's MNTA Position: Q4 2015 in Review

Sivik Global Healthcare sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2015, closing a stake of 90,000 shares — an estimated $1.48M sold.

Sivik Global Healthcare first reported a position in MNTA in Q1 2015 and held it in 3 quarters. The position peaked at $2.51M in Q2 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q4 2015.

  • Sivik Global Healthcare reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Sivik Global Healthcare sold 90,000 Momenta Pharmaceuticals, Inc. shares in Q4 2015, an estimated $1.48M.
  • Sivik Global Healthcare first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Sivik Global Healthcare's Momenta Pharmaceuticals, Inc. position peaked at $2.51M in Q2 2015.
  • 164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2015.

Based on Sivik Global Healthcare's 13F filing for Q4 2015, filed 5 Feb 2016.